The Manufacturers Life Insurance Company lessened its position in Kimberly-Clark Co. (NYSE:KMB – Free Report) by 1.6% in the 3rd quarter, Holdings Channel reports. The fund owned 372,520 shares of the company’s stock after selling 5,945 shares during the period. The Manufacturers Life Insurance Company’s holdings in Kimberly-Clark were worth $53,002,000 at the end of the most recent quarter.
Several other hedge funds have also made changes to their positions in KMB. Wulff Hansen & CO. lifted its position in shares of Kimberly-Clark by 13,720.0% in the 2nd quarter. Wulff Hansen & CO. now owns 641,524 shares of the company’s stock valued at $88,659,000 after acquiring an additional 636,882 shares in the last quarter. Marshall Wace LLP grew its holdings in shares of Kimberly-Clark by 48.4% during the 2nd quarter. Marshall Wace LLP now owns 1,545,147 shares of the company’s stock valued at $213,539,000 after acquiring an additional 503,839 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Kimberly-Clark by 3.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,060,744 shares of the company’s stock valued at $1,431,443,000 after acquiring an additional 358,926 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Kimberly-Clark by 22.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,934,655 shares of the company’s stock valued at $267,383,000 after acquiring an additional 354,501 shares in the last quarter. Finally, Acadian Asset Management LLC grew its holdings in shares of Kimberly-Clark by 32.1% during the 2nd quarter. Acadian Asset Management LLC now owns 1,360,883 shares of the company’s stock valued at $188,040,000 after acquiring an additional 330,327 shares in the last quarter. Hedge funds and other institutional investors own 76.29% of the company’s stock.
Analyst Ratings Changes
Several research firms have recently commented on KMB. Barclays boosted their price target on shares of Kimberly-Clark from $135.00 to $144.00 and gave the company an “equal weight” rating in a report on Friday, October 11th. Royal Bank of Canada restated an “outperform” rating and set a $165.00 price target on shares of Kimberly-Clark in a report on Wednesday, October 23rd. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Kimberly-Clark from $146.00 to $147.00 and gave the company a “hold” rating in a report on Tuesday, October 8th. JPMorgan Chase & Co. reduced their price objective on shares of Kimberly-Clark from $142.00 to $140.00 and set an “underweight” rating for the company in a research note on Wednesday, October 23rd. Finally, UBS Group reduced their price objective on shares of Kimberly-Clark from $153.00 to $151.00 and set a “neutral” rating for the company in a research note on Wednesday, October 23rd. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Kimberly-Clark presently has a consensus rating of “Hold” and a consensus target price of $149.93.
Kimberly-Clark Stock Down 0.4 %
Kimberly-Clark stock opened at $139.20 on Friday. The firm has a market cap of $46.42 billion, a price-to-earnings ratio of 18.05, a P/E/G ratio of 2.92 and a beta of 0.40. The company has a debt-to-equity ratio of 4.77, a current ratio of 0.83 and a quick ratio of 0.55. Kimberly-Clark Co. has a fifty-two week low of $117.67 and a fifty-two week high of $149.30. The firm has a fifty day moving average price of $138.52 and a two-hundred day moving average price of $139.21.
Kimberly-Clark (NYSE:KMB – Get Free Report) last released its earnings results on Tuesday, October 22nd. The company reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.69 by $0.14. The firm had revenue of $4.95 billion during the quarter, compared to analyst estimates of $5.06 billion. Kimberly-Clark had a net margin of 12.97% and a return on equity of 198.59%. The business’s revenue was down 3.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.74 EPS. As a group, analysts forecast that Kimberly-Clark Co. will post 7.27 earnings per share for the current year.
Kimberly-Clark Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 3rd. Stockholders of record on Friday, December 6th will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.51%. The ex-dividend date is Friday, December 6th. Kimberly-Clark’s dividend payout ratio is currently 63.29%.
Insider Activity
In other news, VP Andrew Drexler sold 3,000 shares of the company’s stock in a transaction dated Friday, November 22nd. The shares were sold at an average price of $139.01, for a total transaction of $417,030.00. Following the completion of the transaction, the vice president now owns 5,053 shares of the company’s stock, valued at approximately $702,417.53. This represents a 37.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.62% of the stock is owned by company insiders.
Kimberly-Clark Company Profile
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
See Also
- Five stocks we like better than Kimberly-Clark
- What is the Nasdaq? Complete Overview with History
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Buy P&G Now, Before It Sets A New All-Time High
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Co. (NYSE:KMB – Free Report).
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.